Rewinding RX Review

What Rewinding RX charges

• NAD+: $139/mo — printed as "ONGOING VITALITY PROTOCOL — Monthly NAD+ subscription — $139/month — 1,000mg NAD+ (Monthly Cellular Support) — Ongoing Physician Oversight — Automatic Delivery". The same page also offers a non-recurring alternative: "30-DAY RESET — One month of NAD+ — $149 one-time"
• Sermorelin: $169 — printed on the treatments index as "Rewind Sermorelin — $169.00" with no billing period attached, unlike the same seller's coenzyme product which states "$139/month" explicitly. ⛔ The requested /shop path redirects to /treatments; the effective URL is the one cited

A dose printed next to the price

The coenzyme page describes an ongoing protocol as a monthly subscription, gives a figure with the word month attached, and states the milligram content and the solution volume on the line beneath it.

That combination is unusual here. Most peptide figures on this roster are a number and a period with no quantity at all, which makes them impossible to compare on a cost-per-milligram basis even in principle.

The page also offers a one-time thirty-day option at a higher figure and labels it as a reset for first-timers. Naming which option recurs and which does not, in the product copy rather than in the terms, is a genuinely useful disclosure.

This site records the subscription figure as a monthly rate because the page states a monthly subscription and automatic delivery, and names the one-time alternative in the qualifier.

The growth-hormone figure has no period at all

The treatments index lists the growth-hormone peptide with a figure and a one-line description of how it works. No period is attached — not a month, not a supply length, not a plan term.

The same index lists the coenzyme with the same shape and the same absence, even though its own product page states a monthly subscription explicitly.

So the seller does state a period, on one product, on one page. It does not state one for the growth-hormone peptide anywhere on the pages read.

This site records the growth-hormone figure as one that is not a monthly rate for that reason, rather than borrowing the period from a different product's page.

An LLC and a Ltd. in one document

The about page's body text names the operator as a limited liability company and puts the website address in brackets after it. The footer of the same page, in the same fetch, carries a copyright line naming the same brand as a limited company.

Those are different corporate forms, formed under different regimes. Nothing on the site reconciles them and this review does not pick one.

The terms name a medical practice separately, which is the ordinary and correct split between a brand and the entity delivering care.

Screened by both spellings and by the brand against the regulator's warning-letter index, nothing returns.

A flat-price claim, and a claim about testing

The seller's weight-loss lane carries its own promise of a fixed price at any dose with no memberships or hidden fees. The peptide pages read consistently with that: no membership charge appears in any peptide price line.

The site also carries the words third-party testing on its homepage and a reference to laboratory testing in its informed-consent document. No certificate, PDF or index is reachable from either.

That is the claimed-but-unreachable shape found on several sellers in this batch, and it is recorded here as a claim rather than as testing.

The requested shop path on this site redirects to a differently named page, so a review citing the shop address would be citing a URL the seller does not serve. This roster cites the effective one.

How we verified this

• Loaded the coenzyme product page, the treatments index and the about page with a full browser user-agent, printing the effective URL beside the requested one on each.
• Ran a nonsense-path control on the host in the same run, which returned a not-found status.
• Recorded that the requested shop path redirects to the treatments index, and cited the effective URL rather than the requested one.
• Joined the page's text nodes before matching any figure, so a price split across elements could not read as an absence.
• Read the subscription figure together with the milligram and volume line beneath it, and recorded both in the price row.
• Recorded the growth-hormone figure as one that is not a monthly rate, because its listing states no period, rather than borrowing the period from the coenzyme's page.
• Read the about page's body text and its footer in the same fetch and recorded both corporate forms rather than choosing between them.
• Screened both corporate spellings and the brand against the regulator's warning-letter index, with a nonsense query as a control in the same run.